COMPUT MED IMAG GRAP 润色咨询

COMPUTERIZED MEDICAL IMAGING AND GRAPHICS

出版年份：1988 年文章数：802 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：1.6% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2154241, encodeId=bb5e215424110, content=偏重的研究方向：医学图像处理<br>经验分享：投稿不到两星期就Under Review了（7月底）.但一直到今天同行审阅还没开始（8月下旬）。等等看会有几个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ae8646941, createdName=ms8000002049699940, createdTime=Wed Aug 23 16:25:36 CST 2023, time=2023-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1089155, encodeId=287b10891555b, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089156, encodeId=89cf10891568d, content=投稿时候是否一定要提供每个作者的ORCIDID?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-08-23 ms8000002049699940 来自福建省

    偏重的研究方向：医学图像处理
    经验分享：投稿不到两星期就Under Review了（7月底）.但一直到今天同行审阅还没开始（8月下旬）。等等看会有几个月

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2154241, encodeId=bb5e215424110, content=偏重的研究方向：医学图像处理<br>经验分享：投稿不到两星期就Under Review了（7月底）.但一直到今天同行审阅还没开始（8月下旬）。等等看会有几个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ae8646941, createdName=ms8000002049699940, createdTime=Wed Aug 23 16:25:36 CST 2023, time=2023-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1089155, encodeId=287b10891555b, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089156, encodeId=89cf10891568d, content=投稿时候是否一定要提供每个作者的ORCIDID?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    ORCIDID是什么？怎么注册？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2154241, encodeId=bb5e215424110, content=偏重的研究方向：医学图像处理<br>经验分享：投稿不到两星期就Under Review了（7月底）.但一直到今天同行审阅还没开始（8月下旬）。等等看会有几个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ae8646941, createdName=ms8000002049699940, createdTime=Wed Aug 23 16:25:36 CST 2023, time=2023-08-23, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1089155, encodeId=287b10891555b, content=ORCIDID是什么？怎么注册？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089156, encodeId=89cf10891568d, content=投稿时候是否一定要提供每个作者的ORCIDID?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    投稿时候是否一定要提供每个作者的ORCIDID?

    1

    展开1条回复
共6条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分